Receive the COVID-19 care you deserve including: COVID longhaulers, care for the vaccine injured, vaccine exemption evaluations, ivermectin, hydoxychloroquine and more.
Dr. Shelley Cole and the Healthy Success team provide specialized COVID-19 telemedicine care, emphasizing preventive measures, treatment for long-hauler symptoms, and vaccine-related health issues. The practice utilizes alternative options, including ivermectin, hydroxychloroquine, and ozone therapy, supporting those affected by COVID-19 with personalized, science-backed care. Healthy Success prioritizes addressing root causes over symptom management, focusing on empowering patients with effective solutions for recovery and long-term health.
In light of this very important information, our practice is offering telemedicine consultations and if appropriate prevention and treatment medications for COVID-19. Call (254) 343-7837 today!
Medical Evaluation Form
Dr. Cole is affiliated with the Front Line COVID-19 Critical Care Alliance (FLCCC), an organization committed to improving COVID-19 care and supporting treatment options for patients with COVID-related conditions. Learn more at covid19criticalcare.com.
Our Pandemic Response
February 17, 2023
We continue to care for COVID issues including longhaulers, or acute care of COVID vaccine injuries. We also address vaccine exemption care with a comprehensive evaluation. Fill out our form and we will reach out to you shortly.
September 1, 2021
The number of actively sick patients has significantly increased in August. We are no longer able to accept all who reach out to us regretfully. We will try to do our best. Fill out the COVID-19 form. The fee is $150.
December 14, 2020
I joined other America’s Frontline Doctors at the CDC in Atlanta. We are voicing our concerns about the experimental vaccine that is being distributed today. There are many factors that are concerning regarding the safety and efficacy of the vaccine. The vaccine has only been tested to determine if it lessens symptoms, not the transmission of the virus. It will do nothing to accomplish herd immunity.
September 21, 2020
We are offering hydroxychloroquine and curbside ozone therapy for COVID19 treatment and prevention if appropriate. Please call to schedule a Telemedicine consultation at 254.773.8339. As our commitment to the community, we are charging $125 for consultation and $5 a nominal fee just to cover our expenses for curbside nasal ozone.
July 30, 2020, Immediate Release Shelley G. Cole, MD
The State of Texas emergency revocation of the use of Hydroxychloroquine in prevention expired on July 17, 2020. If appropriate, following telemedicine evaluation, our office is currently taking calls in the state of Texas for care.
We are prioritizing those who are confirmed cases of COVID-19 who are unable to obtain medications.
July 28, 2020
After months of uncertainty, we can now conclude from US data that the COVID-19 death rate is approximately .26%. That is extremely low! Lower than the 2019 or 2018 seasonal flu. Cases are up as more people are tested. As more people have immunity they are less likely to spread it to someone else.
Update: April 10, 2020
We are participating in an international study for the prevention of COVID19. We need your help! Go here to find out how you can be a part of the solution.
Important COVID Information
Scientists from Stanford University School of Medicine, UAB School of Medicine, and the National Academy of Sciences recently reported guidelines from South Korea and China indicating that an antiviral medication can be used as an effective treatment for Coronavirus Disease 2019.
Treatment guidelines using this medication are currently available in South Korea and China and have been reported as “effective treatment measures based on human studies” for COVID-19. The antiviral medication is considered safe and effective and has been utilized for decades in various populations, including children, pregnant women, and nursing mothers. A prescription is required.
A Multi-Center Collaborative Group has established effective treatment measures based on human studies, noting: “This research must be confirmed, and it must also be ruled out that the subjects who had negative viral nucleic acid tests might not have been infected with COVID-19.”
According to human treatment guidelines from South Korea and China, this medication can be implemented today in the U.S., Europe, and the rest of the world. “Countries should immediately authorize and indemnify medical doctors for prescribing” this medication to treat COVID-19.
